FDA Issues Warnings Regarding Testosterone Therapy Heart Attack Risks
May 5th, 2015|
Testosterone is a hormone that helps regulate energy levels, body mass, and sex drive in males. Several medications can raise a man’s testosterone levels, but it’s important to note the U.S. Food and Drug Administration (FDA) has only approved a majority of these drugs to treat certain medical conditions—not low testosterone levels resulting from aging.
Despite the FDA’s regulations, these treatments continue to be prescribed to patients considered unfit to take the drugs. Studies have shown men with a history of heart disease who use low testosterone therapy drugs have an increased Testosterone therapy heart attack risk.
These risks have prompted the FDA to issue a press release warning drug manufacturers and medical professionals about the drug injury risks. Furthermore, the agency issued a press release calling for updates to the labels of low testosterone therapy drugs that would clearly state a warnings to patients.
The FDA goes on to recommend that anyone using a low testosterone therapy drug who experiences symptoms of a heart attack should speak with a medical professional immediately.
At Ferrer, Poirot & Wansbrough, our drug injury lawyers are hopeful these new warnings will be successful in reducing the amount of Low T treatment heart attacks.